five

RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated

收藏
干细胞与再生医学数据中心2022-02-20 更新2024-03-06 收录
下载链接:
http://data.iscr.ac.cn/Article?id=3e592c211dc12db29f86b5ee67c57b71
下载链接
链接失效反馈
官方服务:
资源简介:
To study the senescence gene signatures in the cells, which were genetic SMARCB1 depleted or treated with aurora kinase inhibitors or etoposide, we performed next generation RNA sequencing on these cell, and 'FRIDMAN_SENESCENCE_UP' geneset was used to determine the enrichment of senescence-related genes. The RNA sequencing results include (1) A375 cells and SMARCB1 depleted counterparts. (2) A549 cells and aurora kinase inhibitor (Alisertib, barasertib or tozasertib) or etoposide treated counterparts.
提供机构:
NKI-AVL
创建时间:
2022-02-20
二维码
社区交流群
二维码
科研交流群
商业服务